Warning  We are aware that the website is currently experiencing page load issues. We apologize for the inconvenience caused in the meantime. Please check our twitter here for updates.



Register
Login:
Share:
Email Facebook Twitter


Angus Energy announces transformational joint venture with Cuadrilla & Lucas Energy
Aim-listed Mongolian explorer Petro Matad to drill four wells in 2018


Hemogenyx Share Price (HEMO)



Share Price Information for Hemogenyx (HEMO)


HemoGenyx are creating blood cancer treatments with US$9 billion market potential, click here to see our Exclusive Interview.

Share Price: 2.125Bid: 2.00Ask: 2.25Change: 0.00 (0.00%)No Movement on Hemogenyx
Spread: 0.25Spread as %: 12.50%Open: 2.125High: 2.125Low: 2.125Yesterday’s Close: 2.125

Hemogenyx Pharmaceuticals Plc Ord Gbp0.01

Hemogenyx is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
2.125

Share Price SpacerBid
2.00

Share Price SpacerAsk
2.25

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
333,326

Share Price SpacerOpen
2.125

Share Price SpacerHigh
2.125

Share Price SpacerLow
2.125

Share Price SpacerClose
2.125

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 356.04m £7.57m 30,000

52 Week High 3.25 52 Week High Date 20-NOV-2017
52 Week Low 2.13 52 Week Low Date 20-FEB-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
4 83,326 250,000 -2.656 -0.80 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-Feb-18
15:00:22
2.02
25,000
Sell* 
2.00
2.25
505.00
Trade Type:
Ordinary

21-Feb-18
14:11:59
2.19
250,000
Buy* 
2.00
2.25
5,475
Trade Type:
Ordinary

21-Feb-18
13:51:25
2.00
25,000
Sell* 
2.00
2.25
500.00
Trade Type:
Ordinary




View more Hemogenyx trades >>

Directors Deals for Hemogenyx (HEMO)
Trade DateActionNotifierPriceCurrencyAmountHolding
05-Feb-18Buy
Trade Notifier Information for Hemogenyx Pharmaceuticals
Vladislav Sandler Ph.D. held the position of CEO at Hemogenyx Pharmaceuticals at the time of this trade.
 Vladislav Sandler Ph.D.
2.37GBX26,80040478010
06-Oct-17Buy
Trade Notifier Information for Hemogenyx Pharmaceuticals
Adrian Beeston held the position of Non-Executive Director at Hemogenyx Pharmaceuticals at the time of this trade.
 Adrian Beeston
3.1GBX10,0005424286
06-Oct-17Buy
Trade Notifier Information for Hemogenyx Pharmaceuticals
Peter Redmond held the position of Non-Executive Director at Hemogenyx Pharmaceuticals at the time of this trade.
 Peter Redmond
3.14GBX155,0005040714
View more Hemogenyx directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
8 Feb '18ThechukkersRE: was it worth it? wtf2.125No Opinion
he holds 11% here, more than most i believe...dont get why add so little here either
8 Feb '18Newtoallthis2015RE: was it worth it? wtf2.125No Opinion
Bloody embarrassment thats what it was. This needs to do something! And wheres the warrants right now all lths are being shafted
8 Feb '18kezzmanwas it worth it? wtf2.125No Opinion
Hemogenyx Pharmaceuticals Plc (LSE: HEMO), the biotechnology company developing novel therapies to transform bone marrow, or blood stem cell, transplantation for the treatment of blood diseases, announces that on 5 February 2018 Dr Vladislav Sandler, Chief Executive Officer and Co-Founder of the Company, purchased 26,800 ordinary shares of £0.01 in the Company ("Ordinary Shares") at a price of 2.37 pence per Ordinary Share.

big spender
5 Feb '18Newtoallthis2015Price2.25No Opinion
Price aint looking to clever atm. The only saving grace is knowing all the tr1s paid 3.25p. So they obviously don't want to lose their money
30 Jan '18kezzmanwarrants2.25No Opinion
Received this reply from my broker Hargreaves Landsdown today

Thank you for your email.

We have not received any requests from the Company, or in relation to the Company, for a list of underlying holders, however it is very rare for a Company to go directly to a nominee, rather than through the registrar. I am still awaiting a reply from Computershare but rest assured that we are following up the issue of warrants and will endeavour to get them issued as soon as possible.

I trust this… Read More
26 Jan '18kezzmanwarrants2.375No Opinion
Received reply from Hemo today regards warrants see below

Hi,

Warrant certificates have been sent out to each of the shareholders who hold their shares directly. Do you hold your shares directly or through a nominee account?

If it's via a nominee account then you should contact the nominee as there have been repeated attempts by Hemogenyx to get the details of underlying shareholders so that they can send out the warrant certificates and this might be the case for you.

Kind regards,

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Hemogenyx (HEMO) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.